Ascendis Pharma A/S — insider transactions
5 transactions on record · ASND · CIK 1612042
Aggregates
computed from the filings belowPurchases, 12m
2
count of open-market buys
Sales, 12m
3
count of open-market sales
Buy / sell ratio, 12m
0.67
purchases per sale
Distinct insiders, 12m
2
Bought, 3m
$492.7K
Sold, 3m
$1.1M
Median disclosure lag
1.0 d
trade date to filing date
Largest single trade, 24m
$810.6K
2026-09-08
Director share, 12m
40.0%
of transactions where role is stated
Current run
3 sells
consecutive same-direction transactions
Net 3m flow
-$647.9K
purchases minus sales
Total on record
5
Transactions
5 most recent shown| Disclosed | Traded | Lag, d | Insider | Role | Transaction | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-09 | 2026-09-08 | 1 | Bodenhoff Mads | PAO | Open market sale | 3,000 | $270.19 | $810.6K | filing |
| 2026-09-09 | 2026-09-08 | 1 | Bodenhoff Mads | PAO | Exercise of derivative | 3,000 | $0.00 | — | filing |
| 2026-09-09 | 2026-09-08 | 1 | Bodenhoff Mads | PAO | Exercise of derivative | 3,000 | $110.00 | $330K | filing |
| 2026-08-18 | 2026-08-14 | 4 | BIENAIME JEAN JACQUES | Director | Open market purchase | 900 | $246.91 | $222.2K | filing |
| 2026-08-18 | 2026-08-14 | 4 | BIENAIME JEAN JACQUES | Director | Open market purchase | 1,100 | $245.85 | $270.4K | filing |